Second Continuous Marketing Application Pilot Program Is 44% Enrolled
Executive Summary
Enrollment in FDA's second continuous marketing application pilot program is nearly 50% enrolled
You may also be interested in...
BIO Suggests Re-Evaluation Of Continuous Marketing Application Programs
FDA's continuous marketing application pilot programs may not be worth continuing, the Biotechnology Industry Organization suggested
BIO Suggests Re-Evaluation Of Continuous Marketing Application Programs
FDA's continuous marketing application pilot programs may not be worth continuing, the Biotechnology Industry Organization suggested
FDA Finalizing Review Principles Guidance; Complete Submissions Urged
FDA's guidance on good review management principles is entering the final clearance stage, Office of New Drugs Director John Jenkins, MD, said during the Drug Information Association annual meeting in Washington, D.C. June 16